Research Beyond Borders: Science, Collaboration, Geography
New ideas and new science. As the Company’s ‘radar’ for the next big wave of innovation, the RBB team is tasked with exploring emerging science and technologies. They take an agnostic approach to therapeutic area and modality, which allows them to explore new and disruptive ideas and technologies across the entire research spectrum. But where are the new frontiers in science and how is the team meeting the challenge?
At the frontiers of science
RBB’s current portfolio has a wide, opportunistic horizon: from heart failure to tropical infectious disease and from cystic fibrosis to Duchenne muscular dystrophy. The team is particularly interested in advancing drug discovery in areas of high unmet medical need, or where existing therapies are limited in efficacy, acceptability or applicability. Areas of specific interest include gene therapy, regenerative medicine and the role of the microbiome in human health and disease.
Collaboration is key
The notion of ‘beyond borders’ also extends to how the research is executed – by forging collaborations with the scientific community that blend external innovation and internal expertise. Already involved in key research projects in gene therapy for eye and lung diseases, as well as regenerative medicine, our team has established more than 30 partnerships with world-leading universities and academic research institutions in the USA, Europe and Asia.
Our Partnering Interests in Research Beyond Borders
View or download our infographic to discover how we’re going ‘Beyond Borders’ to explore new and emerging areas of science: Research Beyond Borders @ Boehringer Ingelheim
RBB integrates both internal and external insights and opportunities, and explores new models for collaboration, to bring together the talents and capabilities of our scientists with the strengths of scientists around the world. Find out more about the areas of science we are exploring to build our Research Beyond Borders portfolio: Research Beyond Borders Partnering Interests